Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|January 8, 1997

MBI files for approval of FS069

Molecular Biosystems of San Diego has filed a premarket approvalapplication for FS069, its second-generation ultrasound contrastagent. The submission involved clinical studies for cardiac function,focusing on enhancing endocardial border delineation. In

Molecular Biosystems of San Diego has filed a premarket approvalapplication for FS069, its second-generation ultrasound contrastagent. The submission involved clinical studies for cardiac function,focusing on enhancing endocardial border delineation. In addition,MBI hopes to get approval to use the agent for opacification ofthe left ventricular chamber. MBI has granted Mallinckrodt Medicallicenses to market FS069 in the U.S. and in a number of internationalmarkets (SCAN 12/18/96).

Related to this article

Teleradiology With More Pay and Less Pressure
Expert Radiology is a **radiologist-run teleradiology practice with 10 years of experience**, hiring teleradiologists earning **$500–$900/hr with per-dictation pay**. Work from anywhere with true flexibility, **no shifts, no call, and no weekends**. Our case mix is **predominantly outpatient and noncontrast**, with approximately **75% MRI**, plus X-ray and CT. We cover **malpractice with tail**, handle all medical licensing, and ship you a **$10K reading station with six vertical 4K monitors**. Minimum commitment is an **average of 400 cases per month**. **Book a call with Brandi Escapule, Principal, Physician Services.**
Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.